Dangerous Goods Training - Insights
Self-paced online training and certification for safe collection, handling, packaging, and shipment of specimens.
The prostate health index or phi test reduces the need for prostate cancer biopsies by 30 percent.
Patient-focused pragmatism: The Mayo Clinic innovation model - Insights
In a world of ever-faster technical change, Mayo Clinic Laboratories is uniquely positioned to innovate. Collaboration with clinicians pinpoints unmet patient needs and facilitates the development of diagnostic testing that provides...
Respiratory disease - Insights
Learn about our suite of tests that are designed to detect a variety of respiratory viruses, including COVID-19, influenza, and RSV.
Renal Pathology at Mayo Clinic Laboratories
Mayo Clinic Laboratories’ is integrated with the Renal Biopsy Laboratory in the Department of Laboratory Medicine and Pathology at Mayo Clinic. Board-certified pathologist have a special interest in non-neoplastic disease of the kidney and...
Inflammatory Bowel Disease - Mayo Clinic Laboratories
Inflammatory bowel disease (IBD) is typically classified as either Crohn's disease or ulcerative colitis based on clinical features, colonoscopy findings, histologic changes, and the anatomical distribution of disease. In some cases,...
Rapidly progressive dementia - Insights
Mayo Clinic Laboratories’ first-in-class testing for rapidly progressive dementia and Creutzfeldt-Jakob disease uses a sensitive and specific seed amplification assay that detects and identifies prion proteins in CSF alongside a clinically...
Learn about how our testing for patients with renal, bladder, and prostate cancer identifies the cancer’s genetic traits and helps direct treatment.
Pediatric CNS Disorder Testing - Mayo Clinic Laboratories
We offer a first-of-its-kind profile including only the antibodies that are pertinent to pediatric CNS disorders—all in one evaluation.
Complex testing offers answers and guidance about a lifelong illness - Insights
For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...